Hypoxaemia related to COVID-19 : vascular and perfusion abnormalities on dual-energy CT
| Errataetall: |
CommentIn: Pulmonology. 2021 Jul-Aug;27(4):353-357. - PMID 33272912 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 20(2020), 12 vom: 18. Dez., Seite 1365-1366 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lang, Min [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Fibrin Fibrinogen Degradation Products |
|---|
| Anmerkungen: |
Date Completed 11.12.2020 Date Revised 06.07.2021 published: Print-Electronic CommentIn: Pulmonology. 2021 Jul-Aug;27(4):353-357. - PMID 33272912 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(20)30367-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309430224 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309430224 | ||
| 003 | DE-627 | ||
| 005 | 20231225133907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(20)30367-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309430224 | ||
| 035 | |a (NLM)32359410 | ||
| 035 | |a (PII)S1473-3099(20)30367-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lang, Min |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hypoxaemia related to COVID-19 |b vascular and perfusion abnormalities on dual-energy CT |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.12.2020 | ||
| 500 | |a Date Revised 06.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Pulmonology. 2021 Jul-Aug;27(4):353-357. - PMID 33272912 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Fibrin Fibrinogen Degradation Products |2 NLM | |
| 650 | 7 | |a fibrin fragment D |2 NLM | |
| 700 | 1 | |a Som, Avik |e verfasserin |4 aut | |
| 700 | 1 | |a Mendoza, Dexter P |e verfasserin |4 aut | |
| 700 | 1 | |a Flores, Efren J |e verfasserin |4 aut | |
| 700 | 1 | |a Reid, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Carey, Denston |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Witkin, Alison |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez-Lopez, Josanna M |e verfasserin |4 aut | |
| 700 | 1 | |a Shepard, Jo-Anne O |e verfasserin |4 aut | |
| 700 | 1 | |a Little, Brent P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 20(2020), 12 vom: 18. Dez., Seite 1365-1366 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2020 |g number:12 |g day:18 |g month:12 |g pages:1365-1366 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(20)30367-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2020 |e 12 |b 18 |c 12 |h 1365-1366 | ||